PureTech Health (PRTC) Equity Average (2020 - 2023)
PureTech Health (PRTC) has disclosed Equity Average for 4 consecutive years, with $503.1 million as the latest value for Q4 2023.
- For Q4 2023, Equity Average fell 11.4% year-over-year to $503.1 million; the TTM value through Dec 2023 reached $503.1 million, down 11.4%, while the annual FY2023 figure was $503.1 million, 11.4% down from the prior year.
- Equity Average hit $503.1 million in Q4 2023 for PureTech Health, down from $567.9 million in the prior quarter.
- Across five years, Equity Average topped out at $668.9 million in Q4 2020 and bottomed at $503.1 million in Q4 2023.
- Average Equity Average over 4 years is $592.9 million, with a median of $599.7 million recorded in 2021.
- Year-over-year, Equity Average decreased 5.57% in 2021 and then dropped 11.4% in 2023.
- PureTech Health's Equity Average stood at $668.9 million in 2020, then fell by 5.57% to $631.6 million in 2021, then decreased by 10.1% to $567.9 million in 2022, then decreased by 11.4% to $503.1 million in 2023.
- According to Business Quant data, Equity Average over the past three periods came in at $503.1 million, $567.9 million, and $631.6 million for Q4 2023, Q4 2022, and Q4 2021 respectively.